Navigation Links
GeneTex Introduces New Mouse Monoclonal Antibody Against the Ten-Eleven Translocation 1 (TET1) Protein for DNA Methylation/Epigenetics Research
Date:5/8/2013

IRVINE, Calif., May 8, 2013 /PRNewswire/ -- GeneTex, Inc., a leading manufacturer of antibodies and antibody-related reagents, is introducing a new mouse monoclonal antibody to the human Ten-Eleven Translocation 1 (TET1) protein. The discovery in 2009 (Tahiliani et al, 2009) that this enzyme can convert the DNA methylation mark 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) helped to usher in a new field of research in epigenetics.  Since then, it has become clear that TET1 and its family members TET2 and TET3, through the oxidation of 5mC to 5hmC, 5-formylcytosine (5fC), or 5-carboxylcytosine (5caC), are pivotal factors in epigenetic signaling.

(Logo: http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b)

The excitement generated by the mammalian TET proteins in the last few years is due to their impact on the regulation of DNA methylation, a fundamental epigenetic mechanism that generally causes genes to be turned off through direct methylation of particular cytosines (5mC) in the DNA sequence. The enzymes responsible for this DNA methylation, termed DNA methyltransferases (DNMTs), have been identified and characterized. However, how DNA could be actively demethylated remained a puzzle. It is now thought that the TET enzymes are intimately involved in this process through the conversion of 5mC to 5hmC, 5fC, and 5caC, essentially forming a stepwise pathway to demethylation. Thus, the actions of these enzymes facilitate dynamic regulation of DNA methylation, with the readily apparent implications for development and carcinogenesis.  Even more intriguing to epigenetics researchers, however, is the growing appreciation that these 5mC derivatives, in particular 5hmC, are epigenetic signals in their own right.

TET1 is known to be a challenging protein to develop quality antibodies against and GeneTex is pleased to announce a first to market mouse monoclonal TET1 antibody [GT1462] (GTX627420) that is the most extensively characterized commercially available TET1 antibody.  Qualitative validation has demonstrated that this antibody can detect the human TET1 protein in ICC/IF, IHC-P, and western blot applications.  Importantly, its specificity was verified by both overexpression and siRNA studies. GeneTex also produces polyclonal antibodies against TET1 as well as additional antibodies to TET2, TET3, and 5mC. For more information on GeneTex, Inc. and its products, please call toll-free 877-GENETEX (436-3839) or visit www.genetex.com.

About GeneTex, Inc.

GeneTex, Inc. is an antibody manufacturing company founded in 1997 by a group of internationally renowned academic scientists. They strive to produce the highest quality antibodies and reagents. Their primary and secondary antibodies are created through a process involving extensive research, development, and validation. GeneTex's catalog has grown to over 55,000 primary antibodies and supportive reagents, which are all backed with a 100% Satisfaction Guarantee.

Corporate Mission

We strive to serve and accelerate life science research by creating essential life science tools where quality can be found in every vial.


'/>"/>
SOURCE GeneTex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
2. GeneTex, Inc. to Attend the 2012 Annual Meeting of the American Society for Cell Biology
3. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
4. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
5. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
6. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
7. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
8. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
9. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
10. JPSA Introduces Picosecond Laser Micromachining System
11. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... just published their findings on what they believe could be a new and ... of the new research. Click here to read it now. , ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):